Navigating the complex landscape of ebola infection treatment: A review of emerging pharmacological approaches

F Almeida-Pinto, R Pinto, J Rocha - Infectious Diseases and Therapy, 2024 - Springer
In 1976 Ebola revealed itself to the world, marking the beginning of a series of localized
outbreaks. However, it was the Ebola outbreak that began in 2013 that incited fear and …

RNF185 regulates proteostasis in Ebolavirus infection by crosstalk between the calnexin cycle, ERAD, and reticulophagy

J Zhang, B Wang, X Gao, C Peng, C Shan… - Nature …, 2022 - nature.com
Virus infection affects cellular proteostasis and provides an opportunity to study this cellular
process under perturbation. The proteostasis network in the endoplasmic reticulum (ER) is …

Promising marine natural products for tackling viral outbreaks: a focus on possible targets and structure-activity relationship

M Salampe, SS Mamada, YM Evary… - Current Topics in …, 2023 - ingentaconnect.com
Recently, people worldwide have experienced several outbreaks caused by viruses that
have attracted much interest globally, such as HIV, Zika, Ebola, and the one being faced …

Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection

V Krähling, S Erbar, A Kupke, SS Nogueira, KC Walzer… - Molecular Therapy, 2023 - cell.com
Emerging and re-emerging viruses, such as Zaire Ebola virus (EBOV), pose a global threat
and require immediate countermeasures, including the rapid development of effective …

[HTML][HTML] Ebola virus protein VP40 stimulates IL-12–and IL-18–dependent activation of human natural killer cells

H Le, P Spearman, SN Waggoner, K Singh - JCI insight, 2022 - ncbi.nlm.nih.gov
Accumulation of activated natural killer (NK) cells in tissues during Ebola virus infection
contributes to Ebola virus disease (EVD) pathogenesis. Yet, immunization with Ebola virus …

Ebola virus shed glycoprotein is toxic to human T, B, and natural killer lymphocytes

LJ Perez-Valencia, KM Vannella, MJ Ramos-Benitez… - Iscience, 2023 - cell.com
Lymphocyte depletion is a distinctive feature of Ebola virus (EBOV) disease. The
ectodomain of EBOV glycoprotein (GP) is cleaved off the surface of infected cells into …

RNA editing as a general trait of ebolaviruses

M Mehedi, S Ricklefs, A Takada… - The Journal of …, 2023 - academic.oup.com
RNA editing has been discovered as an essential mechanism for the transcription of the
glycoprotein (GP) gene of Ebola virus but not Marburg virus. We developed a rapid transcript …

Reverse genetics of parrot bornavirus 4 reveals a unique splicing of the glycoprotein gene that affects viral propagation

R Komorizono, K Fujino, S Kessler, S Runge… - Journal of …, 2023 - Am Soc Microbiol
Viruses can utilize host splicing machinery to enable the expression of multiple genes from a
limited-sized genome. Orthobornaviruses use alternative splicing to regulate the expression …

Pharmacokinetics, pharmacodynamics and antiviral efficacy of the MEK inhibitor zapnometinib in animal models and in humans

J Koch-Heier, A Schönsiegel, LM Waidele… - Frontiers in …, 2022 - frontiersin.org
The mitogen-activated protein kinase (MEK) inhibitor zapnometinib is in development to
treat acute viral infections like COVID-19 and influenza. While the antiviral efficacy of …

A bivalent Adenovirus-Vectored Vaccine induces a robust humoral response, but does not protect cynomolgus macaques against a lethal challenge with Sudan virus

S van Tol, P Fletcher, F Feldmann… - The Journal of …, 2024 - academic.oup.com
The most recent Sudan virus (SUDV) outbreak in Uganda was first detected in September
2022 and resulted in 164 laboratory-confirmed cases and 77 deaths. There are no approved …